Surya Narayan Pandey1, Mohit Kwatra1, Durgesh Kumar Dwivedi1, Priyansha Choubey1, Mangala Lahkar2, Ashok Jangra3,4. 1. Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, India. 2. Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India. 3. Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, India. ashok.jangra@kiet.edu. 4. Department of Pharmacology, KIET School of Pharmacy, KIET Group of Institutions, Ghaziabad, Uttar Pradesh, India. ashok.jangra@kiet.edu.
Abstract
RATIONALE: Alcoholism and obesity impart a deleterious impact on human health and affects the quality of life. Chronic consumption of alcohol and western diet has been reported to cause memory deficits. 7,8-dihydroxyflavone (7,8-DHF), a TrkB agonist, comprises antioxidant and anti-inflammatory properties in treating various neurological disorders. OBJECTIVES: The current study was aimed to determine the protective effect and molecular mechanism of 7,8-DHF against alcohol and high-fat diet (HFD)-induced memory deficits in rats. METHODS: The adult male Wistar rats were given alcohol (3-15%) and HFD ad libitum for 12 weeks in different experimental groups. 7,8-DHF (5 mg/kg) was intraperitoneally injected daily for the last 4 weeks (9th-12th week). RESULTS: The alcohol and HFD administration caused cognitive impairment as evaluated through the Morris water maze (MWM) test in alcohol, HFD, and alcohol + HFD-fed animals. The last 4-week treatment of 7,8-DHF (5 mg/kg; i.p.) attenuated alcohol and HFD-induced memory loss. 7,8-DHF treatment also restored the glutathione (GSH) level along with attenuation of nitrite, malondialdehyde content (markers of oxidative and nitrosative stress), and reduction of the acetylcholinesterase activity in the hippocampus of alcohol and HFD-fed animals. Furthermore, the administration of 7,8-DHF caused downregulation of NF-κB, iNOS, and caspase-3 and upregulation of Nrf2, HO-1, and BDNF mRNA level in rat hippocampus. CONCLUSION: 7,8-DHF administration conferred beneficial effects against alcohol and HFD-induced memory deficit via its unique antioxidant, anti-inflammatory, anti-apoptotic potential, along with the activation of TrkB/BDNF signaling pathway in the hippocampus.
RATIONALE: Alcoholism and obesity impart a deleterious impact on human health and affects the quality of life. Chronic consumption of alcohol and western diet has been reported to cause memory deficits. 7,8-dihydroxyflavone (7,8-DHF), a TrkB agonist, comprises antioxidant and anti-inflammatory properties in treating various neurological disorders. OBJECTIVES: The current study was aimed to determine the protective effect and molecular mechanism of 7,8-DHF against alcohol and high-fat diet (HFD)-induced memory deficits in rats. METHODS: The adult male Wistar rats were given alcohol (3-15%) and HFD ad libitum for 12 weeks in different experimental groups. 7,8-DHF (5 mg/kg) was intraperitoneally injected daily for the last 4 weeks (9th-12th week). RESULTS: The alcohol and HFD administration caused cognitive impairment as evaluated through the Morris water maze (MWM) test in alcohol, HFD, and alcohol + HFD-fed animals. The last 4-week treatment of 7,8-DHF (5 mg/kg; i.p.) attenuated alcohol and HFD-induced memory loss. 7,8-DHF treatment also restored the glutathione (GSH) level along with attenuation of nitrite, malondialdehyde content (markers of oxidative and nitrosative stress), and reduction of the acetylcholinesterase activity in the hippocampus of alcohol and HFD-fed animals. Furthermore, the administration of 7,8-DHF caused downregulation of NF-κB, iNOS, and caspase-3 and upregulation of Nrf2, HO-1, and BDNF mRNA level in rat hippocampus. CONCLUSION:7,8-DHF administration conferred beneficial effects against alcohol and HFD-induced memory deficit via its unique antioxidant, anti-inflammatory, anti-apoptotic potential, along with the activation of TrkB/BDNF signaling pathway in the hippocampus.
Authors: L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey Journal: Nature Date: 2000-05-25 Impact factor: 49.962
Authors: R Buettner; K G Parhofer; M Woenckhaus; C E Wrede; L A Kunz-Schughart; J Schölmerich; L C Bollheimer Journal: J Mol Endocrinol Date: 2006-06 Impact factor: 5.098
Authors: Chi Bun Chan; Margaret Chui Ling Tse; Xia Liu; Shuai Zhang; Robin Schmidt; Reed Otten; Liegang Liu; Keqiang Ye Journal: Chem Biol Date: 2015-03-05
Authors: E Bouvier; F Brouillard; J Molet; D Claverie; J-H Cabungcal; N Cresto; N Doligez; C Rivat; K Q Do; C Bernard; J-J Benoliel; C Becker Journal: Mol Psychiatry Date: 2016-09-20 Impact factor: 15.992
Authors: Mariana Alonso; Monica R M Vianna; Amaicha M Depino; Tadeu Mello e Souza; Patricia Pereira; German Szapiro; Haydee Viola; Fernando Pitossi; Ivan Izquierdo; Jorge H Medina Journal: Hippocampus Date: 2002 Impact factor: 3.899
Authors: Jessica R Barson; Olga Karatayev; Guo-Qing Chang; Deanne F Johnson; Miriam E Bocarsly; Bartley G Hoebel; Sarah F Leibowitz Journal: Alcohol Date: 2009-09 Impact factor: 2.405
Authors: Nicholas A Castello; Michael H Nguyen; Jenny D Tran; David Cheng; Kim N Green; Frank M LaFerla Journal: PLoS One Date: 2014-03-10 Impact factor: 3.240
Authors: Vivek Gupta; Nitin Chitranshi; Veer Gupta; Yuyi You; Rashi Rajput; Joao A Paulo; Mehdi Mirzaei; Maarten van den Buuse; Stuart L Graham Journal: Neuroscience Date: 2022-02-23 Impact factor: 3.708
Authors: Palak Ahuja; Chun Fai Ng; Brian Pak Shing Pang; Wing Suen Chan; Margaret Chui Ling Tse; Xinyi Bi; Hiu-Lam Rachel Kwan; Daniel Brobst; Oana Herlea-Pana; Xiuying Yang; Guanhua Du; Suchaorn Saengnipanthkul; Hye Lim Noh; Baowei Jiao; Jason K Kim; Chi Wai Lee; Keqiang Ye; Chi Bun Chan Journal: Autophagy Date: 2021-10-25 Impact factor: 13.391